Radiofrequency Ablation of Solid Benign Thyroid Nodules

Tech Vasc Interv Radiol. 2022 Jun;25(2):100819. doi: 10.1016/j.tvir.2022.100819. Epub 2022 Mar 12.

Abstract

Symptomatic solid benign thyroid nodules may present either as nonfunctioning nodules causing compressive symptoms or as hyperfunctioning nodules causing symptoms of hyperthyroidism. While surgical resection or radioiodine ablation of these nodules can be performed, percutaneous radiofrequency ablation (RFA) of benign solid thyroid nodules has been shown to be a safe and effective alternative in select patients. Preprocedural evaluation should include a history focusing on signs and symptoms of thyroid dysfunction, a physical exam, thyroid ultrasound, thyroid function tests, and discussion of key intraprocedural details with the patient such as the anesthesia plan and risks. Thyroid RFA can be safely performed as an outpatient procedure with less than 2% major and minor complication rates. This report will focus on the basic technique of performing RFA for symptomatic thyroid nodules.

Keywords: Thyroid radiofrequency ablation.

MeSH terms

  • Catheter Ablation* / adverse effects
  • Humans
  • Iodine Radioisotopes
  • Radiofrequency Ablation* / adverse effects
  • Thyroid Nodule* / diagnostic imaging
  • Thyroid Nodule* / surgery
  • Treatment Outcome

Substances

  • Iodine Radioisotopes